Comments

Alvotech Stock Guidance

ALVONASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$5.43
-0.14-2.51%
Last update: Dec 15, 12:04 PM
OverviewNewsEarnings

Guidance

Analyst RatingsShort InterestStock Report

Alvotech Stock Guidance | NASDAQ:ALVO | Benzinga

Alvotech issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
11/12/2025ALVO
Alvotech
FY2025———$570.00M$600.00M$580.48MGet Alert
05/07/2025ALVO
Alvotech
FY2025———$600.00M$700.00M$642.64MGet Alert
03/27/2025ALVO
Alvotech
FY2025———$570.00M$670.00M$629.15MGet Alert
07/01/2024ALVO
Alvotech
Q22024———$196.00M$201.00M$160.00MGet Alert
05/21/2024ALVO
Alvotech
FY2024———$400.00M$500.00M$318.57MGet Alert

FAQ

Q

What is the most recent guidance for Alvotech (ALVO)?

A

There have been no specific sales or earnings guidance reported for Alvotech in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Immunome Inc
NASDAQ:IMNM
$24.10
23.15%
Twist Bioscience Corp
NASDAQ:TWST
$31.14
0.68%
Precigen Inc
NASDAQ:PGEN
$3.84
3.93%
Upstream Bio Inc
NASDAQ:UPB
$27.30
0.59%
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
$20.53
0.76%
Immatics NV
NASDAQ:IMTX
$10.01
-0.30%
NuCana PLC
NASDAQ:NCNA
$3.71
-0.24%
Agios Pharmaceuticals Inc
NASDAQ:AGIO
$27.00
-0.99%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved